Trade VNRX anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
VolitionRx Limited (VNRX) is trading at US$0.44, down 11.78% today as of Aug 28, 13:01 EDT. The company has a market capitalisation of US$5.69M. Over the past 52 weeks, VNRX has traded between US$0.14 and US$3.26. On Syfe you can trade VNRX with $0 commission and add it to your watchlist.
| Previous close | US$0.50 |
|---|---|
| Market cap | US$5.69M |
| 52-week range | US$0.14 – US$3.26 |
| Volume | 349.08M |
| Exchange | US |
Add to Watchlist
Set Price Alert
VolitionRx Limited
VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.
Year: 2007
VolitionRx Collaborates With Japan's Sysmex for Optimization on Platform
Jun 17, 12:59 PM · MT Newswires
VolitionRx Files Patent for Nu.Q NETs Test in Ebola Triage and Monitoring
Jun 3, 1:02 PM · MT Newswires
VolitionRx Limited (VNRX) stock is trading at US$0.44, -11.78% from the previous close of US$0.50.
The market cap for VolitionRx Limited (VNRX) stock is approximately US$5.69M.
The 52-week high for VolitionRx Limited (VNRX) stock is US$3.26.
The 52-week low for VolitionRx Limited (VNRX) stock is US$0.14.
VolitionRx Limited (VNRX) does not currently pay a dividend.
Stay on top of VNRX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
